On September 7, 2013, the "2nd China·Jilin Pharmaceutical and Health Industry Development Forum—Chemical Drug Forum," jointly hosted by the China Biotechnology Development Center and the Jilin Provincial Department of Science and Technology, and organized by the Jilin Provincial Biopharmaceutical Industry Promotion Group Office and the Jilin Provincial Modern Traditional Chinese Medicine and Biopharmaceutical Base Construction Promotion Association, with co-organization from Jilin Bodaweiye Pharmaceutical Co., Ltd., was grandly held in Changchun. Zhang Weihan, Deputy Director of the Jilin Provincial Department of Science and Technology, attended the forum and delivered a speech. Leaders from the provincial science and technology department, representatives from member units of the provincial pharmaceutical industry promotion group, as well as officials responsible for pharmaceutical industry promotion or science and technology management from relevant cities (prefectures), counties (cities, districts), and over 200 participants—including leaders and R&D personnel from universities, research institutions, and pharmaceutical companies across the province—joined the event. The forum was chaired by Duan Chengjun, Chairman of Bodaweiye Pharmaceutical. This year’s forum focused primarily on the innovative development of new chemical drugs. Ding Jian, Director of the Shanghai Institute of Materia Medica, Chinese Academy of Sciences, and an Academician of the Chinese Academy of Engineering, delivered the keynote speech. Additionally, five renowned experts presented at specialized forums: Du Guanhua, Researcher at the Drug Screening Center of Peking Union Medical College; Dr. Zhang Yongxiang, Deputy Minister/Researcher at the Institute of Toxicology and Pharmacology, Academy of Military Medical Sciences; Dr. Zhang Yonghe, Deputy Director of the Peking University Sleep Medicine Center and Associate Director of the Department of Pharmacology at the School of Basic Medical Sciences; and Dr. Liu Jianxun, Chief Researcher at the China Academy of Chinese Medical Sciences and a leading expert in Chinese medicine and pharmacology in China.

On August 28, the finals of the third China Innovation and Entrepreneurship Competition—Jilin Regional Event, jointly hosted by the Jilin Provincial Department of Science and Technology and the Jilin Provincial Committee of the Communist Youth League, successfully concluded in Changchun. A total of 77 enterprises and teams from across the province participated in the competition. During the event, our company showcased our innovative achievements, business model, and future growth prospects. After rigorous evaluation, we were awarded second place in the enterprise category, earning priority support for relevant science and technology projects under the provincial department’s initiatives. Additionally, we were recommended to the Ministry of Science and Technology to compete in the national industry-level round of the third China Innovation and Entrepreneurship Competition. In the national industry-level competition held on September 27, our company once again demonstrated strong performance, securing fifth place in Group 4 and receiving the prestigious "Outstanding Enterprise Award." Awarded the Outstanding Enterprise Prize Competition Highlights Enterprise Showcase

Jilin Boda Weiye Pharmaceutical Co., Ltd. conducted professional knowledge training for its marketing staff from September 3 to 5, 2014, in the conference room on the fourth floor of the company headquarters. Following the training, participants underwent both a question-and-answer-style on-site assessment and a closed-book exam. The training session received high attention from the company's senior management, with Chairman Duan Chengjun and General Manager Xie Wenbo attending throughout and clearly outlining specific expectations for the program. Fully focused and engaged during the professional knowledge closed-book exam.

Chairman Duan Chengjun Accepts Interview with Jilin Provincial Television

In the face of the epidemic, with a mission on our shoulders, Jilin Boda Weiye Pharmaceutical Co., Ltd. promptly responded to the call from the Provincial and Municipal Party Committees as well as the municipal government, fulfilling its social responsibilities and actively demonstrating a sense of duty by taking concrete actions to support the city’s epidemic prevention and control efforts. On February 23, the City Pharmaceutical and Health Industry Chamber of Commerce donated medical supplies worth over 500,000 yuan to the City Central Hospital and the City Chest Hospital. As the leading enterprise of the City Pharmaceutical and Health Industry Chamber of Commerce, Boda Weiye proactively mobilized its member companies to raise funds and coordinate the procurement of medical materials. Despite the significant increase in uncertainties surrounding logistics and transportation, Boda Weiye stepped up to bear the financial risks, making an advance payment of 200,000 yuan to suppliers outside the region. This enabled the urgent coordination of 20,000 medical surgical masks, protective suits, goggles, and other essential防疫 supplies from sources in Henan Province and Russia, effectively addressing the immediate needs of designated hospitals. After learning that Wuhan’s Epidemic Prevention and Control Command Center was seeking specialized gastrointestinal medications nationwide, Boda Weiye immediately reached out to the relevant authorities. On March 5, through the Red Cross Society of China, the company donated Guipu Rui Zinc Granules—a nationally approved Class III new drug valued at 573,000 yuan—to Wuhan. Additionally, Boda Weiye also provided frontline departments at Jilin University First and Third Hospitals with防疫 supplies such as alcohol, disinfectants, and masks, totaling 50,000 yuan in value. On March 3, the Boda Weiye Party Committee organized all its党员 members to participate in a donation drive titled "Caring for Wuhan, Overcoming Difficulties Together." On that day, 25党员 members, led by General Secretary Duan Chengjun, collectively contributed 3,500 yuan, truly embodying their role as a steadfast stronghold in the fight against the epidemic. In times of great crises, true righteousness and profound compassion shine brightest. Xie Wenbo, a member of the Provincial Political Consultative Conference, Standing Committee Member of the Municipal Political Consultative Conference, Executive Vice Chairman of the Municipal New Social Strata Association, and General Manager of Jilin Boda Weiye Pharmaceutical Co., Ltd., has always remained committed to his role as a政协委员, bravely shouldering social responsibilities and setting exemplary examples that highlight the spirit of modern-day political consultants and members of the new social strata. Looking ahead, Xie Wenbo stated that Boda Weiye will continue to follow the overarching guidelines set by the provincial and municipal authorities for epidemic prevention and control, actively pushing forward with the resumption of production while rigorously implementing precise防控 measures. The company is determined to make further contributions to winning the battle against the epidemic.

Polyprone Zinc Granules are a chelated form of zinc combined with L-carnosine, first launched in Japan in 1994 under the brand name Promac. Jilin Province Boda Weiye Pharmaceutical Co., Ltd. was the first to develop a generic version, successfully gaining market approval in 2012. According to relevant research data from its 25 years on the international market, Polyprone Zinc has been widely recognized by nearly 10 million patients suffering from mucosal injury-related conditions. Meanwhile, numerous research institutions overseas have conducted nearly 100 clinical trials to further validate its efficacy and safety.